Literature DB >> 12595969

The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients.

Eugénie C H van den Ham1, Jeroen P Kooman, Maarten L Christiaans, Johannes P van Hooff.   

Abstract

Corticosteroid treatment may have an important effect on body composition and bone mineral density (BMD) in renal transplantation (RTx) patients. We investigated the effect of early steroid withdrawal on body composition and BMD of RTx patients in a prospective design. Post-transplant immunosuppression consisted of tacrolimus, mycophenolate mofetil, and prednisolone. Three months after RTx, 27 patients participating in a multi-center trial were randomized either to continue steroids (at a dose of 10 mg/day, n=17; steroid+) or be withdrawn from steroids within 2 weeks (n=10; steroid-). Body composition and BMD (lumbar spine (L2-L4) and femoral neck) were measured by dual-energy X-ray absorptiometry (DEXA) just before and 3 months after randomization. With regard to body composition, fat mass tended to increase in the steroid+ group (1.1+/-2.3 kg; P=0.084), but did not change in the steroid- group. Increase in body fat percentage tended to be higher (P=0.08) in the steroid+ group (0.6+/-2.7%) than in the steroid- group (-0.7+/-2.1%). The change in lean body mass was not significantly different between the two groups. BMD of the lumbar spine and femoral neck decreased significantly in the steroid+ group (-1.4+/-3.2% and -2.3+/-2.9%, respectively, P<0.05) while no changes were observed in the steroid- group. The change in BMD of the lumbar spine was significantly different between the steroid+ and the steroid- group, whereas the change in BMD of the femoral neck was not significantly different. Thus, the increase in fat mass tended to be higher in the group continuing on steroids, though not significant, due to large inter-individual variation. In general, the effect of early steroid withdrawal on body composition after RTx appears to be modest. In addition, early steroid withdrawal seems to have beneficial effects on BMD in RTx patients, especially in the lumbar region.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595969     DOI: 10.1007/s00147-002-0488-8

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  14 in total

Review 1.  Osteoporosis after renal transplantation.

Authors:  Evangelia Dounousi; Konstantinos Leivaditis; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Int Urol Nephrol       Date:  2014-11-11       Impact factor: 2.370

Review 2.  Physical inactivity: a risk factor and target for intervention in renal care.

Authors:  Dorien M Zelle; Gerald Klaassen; Edwin van Adrichem; Stephan J L Bakker; Eva Corpeleijn; Gerjan Navis
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

Review 3.  Management of mineral and bone disorder after kidney transplantation.

Authors:  Kamyar Kalantar-Zadeh; Miklos Z Molnar; Csaba P Kovesdy; Istvan Mucsi; Suphamai Bunnapradist
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

Review 4.  Mineral and bone disorder after kidney transplantation.

Authors:  Pahnwat T Taweesedt; Sinee Disthabanchong
Journal:  World J Transplant       Date:  2015-12-24

5.  Reduced fracture risk with early corticosteroid withdrawal after kidney transplant.

Authors:  L E Nikkel; S Mohan; A Zhang; D J McMahon; S Boutroy; G Dube; B Tanriover; D Cohen; L Ratner; C S Hollenbeak; M B Leonard; E Shane; T L Nickolas
Journal:  Am J Transplant       Date:  2011-12-07       Impact factor: 8.086

6.  Micro-MR imaging-based computational biomechanics demonstrates reduction in cortical and trabecular bone strength after renal transplantation.

Authors:  Chamith S Rajapakse; Mary B Leonard; Yusuf A Bhagat; Wenli Sun; Jeremy F Magland; Felix W Wehrli
Journal:  Radiology       Date:  2012-03       Impact factor: 11.105

Review 7.  Bone and mineral disorders after kidney transplantation: therapeutic strategies.

Authors:  Miklos Z Molnar; Mohamed S Naser; Connie M Rhee; Kamyar Kalantar-Zadeh; Suphamai Bunnapradist
Journal:  Transplant Rev (Orlando)       Date:  2013-12-12       Impact factor: 3.943

Review 8.  Renal transplantation with early steroid withdrawal.

Authors:  Jeffrey Schiff; Edward H Cole
Journal:  Pediatr Nephrol       Date:  2008-06-06       Impact factor: 3.714

9.  Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation.

Authors:  F Atamaz; S Hepguler; M Akyildiz; Z Karasu; M Kilic
Journal:  Osteoporos Int       Date:  2006-03-21       Impact factor: 4.507

Review 10.  Mineral and bone disorder after renal transplantation: a review.

Authors:  Hazim Sadideen; Adrian Covic; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2007-12-18       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.